Empagliflozin and Metformin Extended-Release Tablets and Hyperlipidemia
Result of checking the interaction of drug Empagliflozin and Metformin Extended-Release Tablets and disease Hyperlipidemia for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:There have been reports of dose-related increases in LDL cholesterol with the use of SGLT-2 inhibitors. Cholesterol levels should be monitored before and during treatment and appropriate therapy should be initiated if needed.
Generic Name: empagliflozin / metformin
Brand Name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
Empagliflozin and Metformin Extended-Release Tablets - hiperlipidemia 
Empagliflozin and Metformin Extended-Release Tablets - hiperlipidemia 
Empagliflozin and Metformin Extended-Release Tablets - hiperlipidemia 
Empagliflozin and Metformin Extended-Release Tablets - hiperlipidemia 
Empagliflozin and Metformin Extended-Release Tablets - iperlipidemia 
Empagliflozin and Metformin Extended-Release Tablets - hyperlipidémie 
Empagliflozin and Metformin Extended-Release Tablets - Hyperlipidämie 
Empagliflozin and Metformin Extended-Release Tablets - hiperlipidemia 
Empagliflozin and Metformin Extended-Release Tablets - гиперлипидемия 
Empagliflozin and Metformin Extended-Release Tablets - hiperlipidemi 
Empagliflozin and Metformin Extended-Release Tablets - ارتفاع شحوم الدم 
Empagliflozin and Metformin Extended-Release Tablets - 高脂血症